EMA/PE/0000241527 - paediatric investigation plan
baxdrostat
dapagliflozin propanediol
PIPHuman
Greek is available via eTranslation, the European Commission's machine translation service.
Translate to Greek | Important information about machine translation
Key facts
- Active substance
- baxdrostat
- dapagliflozin propanediol
- Therapeutic area
- Cardiac disorders
- Decision number
- EMA/PE/0000241527
- PIP number
- EMA/PE/0000241527
- Pharmaceutical form(s)
- Tablet
- Condition(s) / indication(s)
- Prevention of heart failure
- Route(s) of administration
- Oral use
- Contact for public enquiries
AstraZeneca AB
E-mail: paediatrics@astrazeneca.com- Decision type
- P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
- Decision date
- Compliance check done
- Όχι